• Company
• Chong Kun Dang hastens way into diabetes Tx market
• by Kim, Jin-Gu Jun 12, 2023 05:42am

• Policy
• When will the innovative generic price system be improved?
• by Lee, Tak-Sun Jun 12, 2023 05:42am

• Company
• Crystal Genomics supplies 2.6 billion Acelex to Russia
• by Lee, Seok-Jun Jun 9, 2023 05:36am

• Policy
• Adtralza is about to be approved in Korea
• by Lee, Hye-Kyung Jun 9, 2023 05:35am

• Company
• Korea’s new drug reimb rate is below OECD average
• by Eo, Yun-Ho Jun 9, 2023 05:35am

• Company
• Non-covalent BTKi pirtobrutinib receives orphan drug desig
• by Eo, Yun-Ho Jun 9, 2023 05:35am

• Company
• Humira with sales of 100 billion won
• by Chon, Seung-Hyun Jun 9, 2023 05:35am

• Company
• Daewoong,"promoting to change Fexuprazan's partner"
• by Kim, Jin-Gu Jun 8, 2023 07:47pm

• Company
• Competition for interleukin inhibitors heats up in Stelara
• by Kim, Jin-Gu Jun 8, 2023 05:34am

• Company
• K-Bio appealed for its competitiveness in Bio USA
• by Hwang, Jin-joon Jun 8, 2023 05:33am